Medicine catalog

Search official names, active ingredients, and BDPM codes. Cards show a readable name and form; the exact French source details are available below.

Total in catalog: 20,854 · 8 shown

Commercialized according to BDPM

SOTYKTU 6 mg, film-coated tablet

Active ingredients: DEUCRAVACITINIB

Original BDPM details in French

Official name: SOTYKTU 6 mg, comprimé pelliculé
Active ingredients: DEUCRAVACITINIB
Package description: plaquette(s) avec calendrier PVC polychlortrifluoroéthylène aluminium de 28 comprimé(s)

CIS 69187374CIP7 3026930CIP13 3400930269305

View details

Estimated price€1,131.98No current ANSM shortage notice is included

Commercialized according to BDPM

RINVOQ 15 mg, extended-release tablet

Active ingredients: Upadacitinib, Upadacitinib hemihydrate

Original BDPM details in French

Official name: RINVOQ 15 mg, comprimé à libération prolongée
Active ingredients: UPADACITINIB, UPADACITINIB HÉMIHYDRATÉ
Package description: plaquette(s) PVC polyéthylène polychlortrifluoroéthylène aluminium avec calendrier de 28 comprimé(s)

CIS 65852428CIP7 3019398CIP13 3400930193983

View details

Estimated price€1,255.00No current ANSM shortage notice is included

Commercialized according to BDPM

RINVOQ 30 mg, extended-release tablet

Active ingredients: Upadacitinib, Upadacitinib hemihydrate

Original BDPM details in French

Official name: RINVOQ 30 mg, comprimé à libération prolongée
Active ingredients: UPADACITINIB, UPADACITINIB HÉMIHYDRATÉ
Package description: plaquette(s) PVC polyéthylène polychlortrifluoroéthylène aluminium avec calendrier de 28 comprimé(s)

CIS 62457931CIP7 3023400CIP13 3400930234006

View details

Estimated price€2,202.40No current ANSM shortage notice is included

Commercialized according to BDPM

RINVOQ 45 mg, extended-release tablet

Active ingredients: Upadacitinib, Upadacitinib hemihydrate

Original BDPM details in French

Official name: RINVOQ 45 mg, comprimé à libération prolongée
Active ingredients: UPADACITINIB, UPADACITINIB HÉMIHYDRATÉ
Package description: plaquette(s) PVC polyéthylène polychlortrifluoroéthylène aluminium avec calendrier de 28 comprimé(s)

CIS 66709721CIP7 3025473CIP13 3400930254738

View details

Estimated price€1,621.64No current ANSM shortage notice is included

Commercialized according to BDPM

XELJANZ 10 mg, film-coated tablet

Active ingredients: Tofacitinib citrate, Tofacitinib

Original BDPM details in French

Official name: XELJANZ 10 mg, comprimé pelliculé
Active ingredients: CITRATE DE TOFACITINIB, TOFACITINIB
Package description: plaquette(s) aluminium PVC de 56 comprimé(s)

CIS 61342424CIP7 3015945CIP13 3400930159453

View details

Estimated price€2,470.34No current ANSM shortage notice is included

Commercialized according to BDPM

XELJANZ 11 mg, extended-release tablet

Active ingredients: Tofacitinib citrate, Tofacitinib

Original BDPM details in French

Official name: XELJANZ 11 mg, comprimé à libération prolongée
Active ingredients: CITRATE DE TOFACITINIB, TOFACITINIB
Package description: plaquette(s) aluminium PVC-Aluminium de 28 comprimés

CIS 66610933CIP7 3019989CIP13 3400930199893

View details

Estimated price€1,270.54No current ANSM shortage notice is included

Commercialized according to BDPM

XELJANZ 5 mg, film-coated tablet

Active ingredients: Tofacitinib citrate, Tofacitinib

Original BDPM details in French

Official name: XELJANZ 5 mg, comprimé pelliculé
Active ingredients: CITRATE DE TOFACITINIB, TOFACITINIB
Package description: plaquette(s) aluminium PVC de 56 comprimé(s)

CIS 68330200CIP7 3008811CIP13 3400930088111

View details

Estimated price€1,270.54No current ANSM shortage notice is included

Commercialized according to BDPM

ANZUPGO 20 mg/g, cream

Active ingredients: Delgocitinib

Original BDPM details in French

Official name: ANZUPGO 20 mg/g, crème
Active ingredients: DELGOCITINIB
Package description: 1 tube(s) laminé polyéthylène basse densité (PEBD) de 60 g

CIS 61015604CIP7 3030309CIP13 3400930303092

View details

Estimated price€1,097.68No current ANSM shortage notice is included

The displayed price is an estimate. It is not an offer to sell or confirmation of stock. Current catalog version published 4 Nov 2026.